Virtual Reality to Enhance Upper Extremity Physical Therapy and Recovery

This is a descriptive study assessing the feasibility of using VR rehabilitation with unilateral (or bilateral) impairment of the arm, wrist and or hand resulting in reduced range of motion, dexterity, and/or strength of the hand.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The purpose of this study is to determine the feasibility of using a virtual reality program to monitor and encourage compliance with musculoskeletal home exercise programs. It hypothesizes that the treatment will display improved compliance, range of motion, and general function for individuals with upper extremity musculoskeletal deficits.

The primary objectives are to: 1. Describe participant compliance with an immersive game-based virtual reality (VR) rehabilitation device for delivering at-home occupational therapy exercises for the wrist and hand in individuals with motor impairments. 2. Describe and compare functional outcomes among participants before and after completing at-home rehabilitation using the VR system.

These objective outcomes will be measured through various standardized tests completed by qualified study team members.

Study Type

Interventional

Enrollment (Anticipated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • DoD Beneficiary
  • Exhibiting musculoskeletal impairment requiring continued at-home rehabilitation
  • Cleared by research or clinical medical provider for participation
  • Participant no longer has active range of motion movement restrictions. They may still have weight bearing restrictions but nothing that will preclude them from moving their hand and digits to their maximum ability.
  • Ability to keep hand and arm in the field of view of the VR scene
  • Must have demonstrated the ability for the Oculus to track all hand and wrist motions of interest (during an initial screening at baseline)
  • Ability to independently don and doff the VR headset, plus start the app (verified in the Occupational Therapy/Physical Therapy clinic)
  • Age range between 18-65
  • Demonstrate the ability to tolerate wearing the VR headset

Exclusion Criteria:

  • History of photo-induced seizures
  • History of motion sickness when using VR equipment (especially vestibular effects such as nausea, dizziness, etc.)
  • Partial amputations of the arm being assessed (including missing digits as they may not enable tracking by the VR)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Reality to Enhance Upper Extremity Physical Therapy and Recovery
This is a descriptive study assessing the feasibility of using VR rehabilitation with unilateral (or bilateral) impairment of the arm, wrist, and or hand resulting in reduced range of motion, dexterity, and/or strength of the hand. Phase I: Typical Home Exercise Program, Phase II: Use of VR headset in conjunction with current Home Exercise Program. Intervention sessions include the baseline, midpoint and final visits.
The Meta/Oculus Quest (along with the SignWave software) delivers an immersive audio/visual-based game environment where the users hand is created and displayed in the virtual environment and matches target gestures to the beat of the music.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Jebsen-Taylor Hand Function Test
Time Frame: 30 minutes
Assessment of functional use and selection of appropriate grasp for common activities of daily living
30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
9-hole Peg Test
Time Frame: 10 minutes
Speed and accuracy of grasp and release
10 minutes
Hand/wrist goniometric range of motion (ROM)
Time Frame: 15 minutes
Hand/wrist range of motion assessment
15 minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quick DASH (Disabilities of the Arm, Shoulder and Hand) Questionnaire
Time Frame: 5 minutes
Self-reported perception of functional ability of arm, shoulder, and hand
5 minutes
NASA-TLX
Time Frame: 5 minutes
Ease of use preference and mental load survey
5 minutes
System Usability Scale
Time Frame: 2 minutes
Quantitative ease of use assessment
2 minutes
Open-Ended Usability Scale
Time Frame: 2 minutes
Qualitative ease of use assessment
2 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2023

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

April 27, 2023

First Submitted That Met QC Criteria

April 27, 2023

First Posted (Estimate)

May 5, 2023

Study Record Updates

Last Update Posted (Estimate)

May 5, 2023

Last Update Submitted That Met QC Criteria

April 27, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • WRNMMC-2021-0376

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Injuries to the Hand and Wrist

Clinical Trials on Meta Quest 2

3
Subscribe